These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 23737472)

  • 21. Subfoveal choroidal thickness after treatment of central serous chorioretinopathy.
    Maruko I; Iida T; Sugano Y; Ojima A; Ogasawara M; Spaide RF
    Ophthalmology; 2010 Sep; 117(9):1792-9. PubMed ID: 20472289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. En face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathy.
    Ferrara D; Mohler KJ; Waheed N; Adhi M; Liu JJ; Grulkowski I; Kraus MF; Baumal C; Hornegger J; Fujimoto JG; Duker JS
    Ophthalmology; 2014 Mar; 121(3):719-26. PubMed ID: 24289918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multimodal Imaging in Fibrinous Central Serous Chorioretinopathy Compared with Exudative Maculopathy.
    Lyu Y; Li X; Gong Y
    Ophthalmologica; 2020; 243(5):360-369. PubMed ID: 32008002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphologic choroidal and scleral changes at the macula in tilted disc syndrome with staphyloma using optical coherence tomography.
    Maruko I; Iida T; Sugano Y; Oyamada H; Sekiryu T
    Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8763-8. PubMed ID: 21989725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multimodal Imaging and Choroidal Volumetric Changes After Half-fluence PDT in Central Serous Chorioretinopathy.
    Munk MR; Shah R; Pappas F; Baddar D; Wong B; Jampol LM; Fawzi AA
    Curr Eye Res; 2016; 41(1):97-106. PubMed ID: 25612245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and spectral-domain optical coherence tomography findings in patients with focal choroidal excavation.
    Lee CS; Woo SJ; Kim YK; Hwang DJ; Kang HM; Kim H; Lee SC
    Ophthalmology; 2014 May; 121(5):1029-35. PubMed ID: 24439757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultra-widefield imaging with autofluorescence and indocyanine green angiography in central serous chorioretinopathy.
    Pang CE; Shah VP; Sarraf D; Freund KB
    Am J Ophthalmol; 2014 Aug; 158(2):362-371.e2. PubMed ID: 24794091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Punctate hyperfluorescence spot as a common choroidopathy of central serous chorioretinopathy and polypoidal choroidal vasculopathy.
    Park SJ; Kim BH; Park KH; Woo SJ
    Am J Ophthalmol; 2014 Dec; 158(6):1155-1163.e1. PubMed ID: 25127698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Changes of choroidal thickness in central serous chorioretinopathy].
    Yang LH; Tian B; Shi XH; Ding N; Zhou D; Wei WB
    Zhonghua Yan Ke Za Zhi; 2012 Oct; 48(10):874-7. PubMed ID: 23302239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. En face choroidal vascular feature imaging in acute and chronic central serous chorioretinopathy using swept source optical coherence tomography.
    Lee WJ; Lee JW; Park SH; Lee BR
    Br J Ophthalmol; 2017 May; 101(5):580-586. PubMed ID: 27485721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in Choroidal Structures in Eyes with Chronic Central Serous Chorioretinopathy after Half-Dose Photodynamic Therapy.
    Kinoshita T; Mitamura Y; Mori T; Akaiwa K; Semba K; Egawa M; Mori J; Sonoda S; Sakamoto T
    PLoS One; 2016; 11(9):e0163104. PubMed ID: 27636093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy.
    Imamura Y; Fujiwara T; Margolis R; Spaide RF
    Retina; 2009; 29(10):1469-73. PubMed ID: 19898183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study of subretinal exudation and consequent changes in acute central serous chorioretinopathy by optical coherence tomography.
    Yu J; Jiang C; Xu G
    Am J Ophthalmol; 2014 Oct; 158(4):752-756.e2. PubMed ID: 24973608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morphologic changes in acute central serous chorioretinopathy evaluated by fourier-domain optical coherence tomography.
    Fujimoto H; Gomi F; Wakabayashi T; Sawa M; Tsujikawa M; Tano Y
    Ophthalmology; 2008 Sep; 115(9):1494-500, 1500.e1-2. PubMed ID: 18394706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration.
    Fung AT; Yannuzzi LA; Freund KB
    Retina; 2012 Oct; 32(9):1829-37. PubMed ID: 22850219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of the choroid in central serous chorioretinopathy].
    Maruko I
    Nippon Ganka Gakkai Zasshi; 2012 Nov; 116(11):1062-79. PubMed ID: 23316655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biometric characteristics of eyes with central serous chorioretinopathy.
    Oh JH; Oh J; Togloom A; Kim SW; Huh K
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1502-8. PubMed ID: 24550360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. OPTICAL COHERENCE TOMOGRAPHIC ANGIOGRAPHY IN CENTRAL SEROUS CHORIORETINOPATHY.
    Chan SY; Wang Q; Wei WB; Jonas JB
    Retina; 2016 Nov; 36(11):2051-2058. PubMed ID: 27164548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of choroidal topographic changes by swept source optical coherence tomography after photodynamic therapy for central serous chorioretinopathy.
    Razavi S; Souied EH; Cavallero E; Weber M; Querques G
    Am J Ophthalmol; 2014 Apr; 157(4):852-60. PubMed ID: 24412124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical characteristics of pachydrusen in central serous chorioretinopathy.
    Matsumoto H; Mukai R; Morimoto M; Tokui S; Kishi S; Akiyama H
    Graefes Arch Clin Exp Ophthalmol; 2019 Jun; 257(6):1127-1132. PubMed ID: 30852634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.